Chlamydia trachomatis: Difference between revisions
From IDWiki
Chlamydia trachomatis
m (Text replacement - "[[Has shape::" to "[[Cellular shape::") |
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
||
| Line 7: | Line 7: | ||
* Virulence factors include lipopolysaccharide (LPS) |
* Virulence factors include lipopolysaccharide (LPS) |
||
== Clinical |
== Clinical Manifestationss == |
||
* Presentation varies by serovar |
* Presentation varies by serovar |
||
Revision as of 02:11, 15 July 2020
Microbiology
- Small, obligate intracellular Gram-negative coccobacillus
- Very difficult to Gram stain due to lack of peptidoglycan in cell wall
- Two forms exist:
- Elementary body (EB): spore-like form than can survive short times outside the body
- Reticulate body (RB): replicative form
- Virulence factors include lipopolysaccharide (LPS)
Clinical Manifestationss
- Presentation varies by serovar
| Serovars | Syndromes |
|---|---|
| D to K | Urethritis, PID, neonatal infection |
| A to C | Trachoma (chronic conjunctivitis) |
| L1 to L3 | Lymphogranuloma venereum (LGV) |
Urethritis
- In men, most are symptomatic
- Incubation or 7 to 21 days in men
- Purulent urethritis
- In women, often asymptomatic
Fitz-Hugh-Curtis syndrome
- Liver capsular inflammation, possibly autoimmune
Diagnosis
- Urine NAAT ~80% sensitive
- Self-collected vaginal swab better
- MD-collected cervical swab best (90+%)
- No more serology!
Management
- For serovars L1-L3 (LGV): treat for 21 days
- In pregnant women, azithromycin is best
